The diagnostic impact of testicular biopsies for intratubular germ cell neoplasia in cryptorchid boys and the subsequent risk of testicular cancer in men with prepubertal surgery for syndromic or non-syndromic cryptorchidism. 2017

Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
The Department of Paediatric Surgery, Copenhagen University Hospital Rigshospitalet, DK-2100, Copenhagen.

BACKGROUND Cryptorchidism is a risk factor for testicular cancer in adult life. It remains unclear how prepubertal surgery for cryptorchidism impacts later development of adult testicular cancer. The aim of study was to investigate tools to identify the cryptorchid boys who later develop testicular cancer. METHODS The study cohort consisted of 1403 men operated prepubertally/pubertally for undescended testis between 1971 and 2003. At surgery testicular biopsies were taken from the cryptorchid testes. The boys were followed for occurrence of testicular cancer. The testicular cancer risk was compared to the risk in the Danish Population. Testicular biopsies from the boys who developed testicular cancer during follow-up underwent histological examination with specific diagnostic immunohistochemical markers for germ cell neoplasia. RESULTS The cohort was followed for 33,627 person years at risk. We identified 16 cases with testicular cancer in adulthood. The standardized incidence ratio was 2.66 (95% CI: 1.52-4.32). At time of primary surgery in prepubertal/pubertal age Intratubular Germ Cell Neoplasia (ITGCN) was diagnosed in 5 cases and the boys were unilaterally orchiectomized. At follow-up new immunohistochemical staining indicated ITGCN in two of the 16 cancer cases at reevaluation of the original biopsies from time of prepubertal/pubertal surgery. One had syndromic cryptorchid and developed seminoma, and another showed nonsyndromic cryptorchidism and developed embryonic teratocarcinoma. Totally, ITGCN was diagnosed in 0.5% (7/1403) of prepubertal cryptorchid boys, whereof 57% (4/7) in syndromic-cryptorchidism. CONCLUSIONS ITGCN is predominantly observed prepubertally in boys with syndromic-cryptorchidism. In nonsyndromic cryptorchidism testicular cancer develops postpubertally, generally not based on dormant germ cells of ITGCN caused by an early fetal maldevelopment. METHODS LEVEL I.

UI MeSH Term Description Entries
D008297 Male Males
D009373 Neoplasms, Germ Cell and Embryonal Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS. Germ Cell Cancer,Germ Cell Tumor,Neoplasms, Embryonal and Mixed,Cancer, Embryonal,Cancer, Embryonal and Mixed,Embryonal Neoplasms,Germ Cell Neoplasms,Germ Cell and Embryonal Neoplasms,Germ Cell and Embryonic Neoplasms,Neoplasms, Embryonal,Neoplasms, Germ Cell,Neoplasms, Germ Cell and Embryonic,Cancer, Germ Cell,Cancers, Embryonal,Cancers, Germ Cell,Embryonal Cancer,Embryonal Cancers,Embryonal Neoplasm,Germ Cell Cancers,Germ Cell Tumors,Neoplasm, Embryonal,Tumor, Germ Cell,Tumors, Germ Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003456 Cryptorchidism A developmental defect in which a TESTIS or both TESTES failed to descend from high in the ABDOMEN to the bottom of the SCROTUM. Testicular descent is essential to normal SPERMATOGENESIS which requires temperature lower than the BODY TEMPERATURE. Cryptorchidism can be subclassified by the location of the maldescended testis. Testis, Undescended,Abdominal Cryptorchidism,Bilateral Cryptorchidism,Cryptorchidism, Unilateral Or Bilateral,Cryptorchism,Inguinal Cryptorchidism,Testes, Undescended,Undescended Testis,Unilateral Cryptorchidism,Cryptorchidism, Abdominal,Cryptorchidism, Bilateral,Cryptorchidism, Inguinal,Cryptorchidism, Unilateral,Undescended Testes
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
April 2014, The Journal of urology,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
February 2012, Fetal and pediatric pathology,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
April 2013, Iranian journal of reproductive medicine,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
January 1994, Journal of andrology,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
May 2008, Nature clinical practice. Urology,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
January 1984, Cleveland Clinic quarterly,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
June 2002, European urology,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
April 1990, Human pathology,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
December 2005, Journal of clinical pathology,
Lene Osterballe, and Erik Clasen-Linde, and Dina Cortes, and Gerda Engholm, and Rasmus Hertzum-Larsen, and Susanne Reinhardt, and Jorgen Thorup
July 2000, Urology,
Copied contents to your clipboard!